Alnara Therapeutics Inc.,a Cambridge,Mass.-based developer of orally-delivered protein therapeutics for the treatment of metabolic diseases,has raised $35 million in Series B funding.MPM Capital led the round,and was joined by return backers Third Rock Ventures,Frazier Healthcare and Bessemer Ventur [...]